PDCD1 and cancer: However, the latter study found that combination of transfer of SHP-1–/– T cells and anti-PD-1 treatment improved control of tumor growth indicating that therapies that combine inhibitory molecules blockade and ACT with T cells lacking PTPs could be a beneficial strategy for cancer treatment.